<!DOCTYPE html>
<html lang="en">

<head>
  <meta http-equiv="content-type" content="text/html; charset=utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <meta name="description" content="">
  <meta name="generator" content="Hugo 0.18.1" />

  <title>Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer. &middot; seandavi(s12)</title>

  
  
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/pure/1.0.0/pure-min.css">

  <!--[if lte IE 8]>
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/pure/1.0.0/grids-responsive-old-ie-min.css">
  <![endif]-->
  <!--[if gt IE 8]><!-->
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/pure/1.0.0/grids-responsive-min.css">
  <!--<![endif]-->

  <!--[if lte IE 8]>
  <link rel="stylesheet" href="/css/side-menu-old-ie.css">
  <![endif]-->
  <!--[if gt IE 8]><!-->
  <link rel="stylesheet" href="/css/side-menu.css">
  <!--<![endif]-->

  <link rel="stylesheet" href="/css/blackburn.css">

  
  <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css">

  
  <link href="https://fonts.googleapis.com/css?family=Raleway" rel="stylesheet" type="text/css">

  
  

  
  <link rel="stylesheet" href="//cdnjs.cloudflare.com/ajax/libs/highlight.js/9.12.0/styles/androidstudio.min.css">
  <script src="//cdnjs.cloudflare.com/ajax/libs/highlight.js/9.12.0/highlight.min.js"></script>
  
  <script src="//cdnjs.cloudflare.com/ajax/libs/highlight.js/9.12.0/languages/yaml.min.js"></script>
  
  <script>hljs.initHighlightingOnLoad();</script>
  

  <link rel="shortcut icon" href="/img/favicon.ico" type="image/x-icon" />

  
  

</head>


<body>
<div id="layout">

  
<a href="#menu" id="menuLink" class="menu-link">
  
  <span></span>
</a>
<div id="menu">

  
  <a class="pure-menu-heading brand" href="/">seandavi(s12)</a>


  <div class="pure-menu">
    <ul class="pure-menu-list">
      
      
        <li class="pure-menu-item">
          <a class="pure-menu-link" href="/"><i class='fa fa-home fa-fw'></i>Home</a>
      
        </li>
      
      
        <li class="pure-menu-item">
          <a class="pure-menu-link" href="/post/"><i class='fa fa-list fa-fw'></i>Posts</a>
      
        </li>
      
      
        <li class="pure-menu-item">
          <a class="pure-menu-link" href="/talk/"><i class='fa fa-microphone fa-fw'></i>Talks</a>
      
        </li>
      
      
        <li class="pure-menu-item">
          <a class="pure-menu-link" href="/about/"><i class='fa fa-user fa-fw'></i>About</a>
      
        </li>
      
      
        <li class="pure-menu-item">
          <a class="pure-menu-link" href="/publication/"><i class='fa fa-file-text fa-fw'></i>Publications</a>
      
        </li>
      
    </ul>
  </div>

  <div class="pure-menu social">
  <ul class="pure-menu-list">

    

    

    
    <li class="pure-menu-item">
      <a class="pure-menu-link" href="https://twitter.com/seandavis12" target="_blank"><i class="fa fa-twitter-square fa-fw"></i>Twitter</a>
    </li>
    

    

    

    

    

    

    

    

    

    

    

    

    

    

    
    <li class="pure-menu-item">
      <a class="pure-menu-link" href="http://slideshare.net/seandavi" target="_blank"><i class="fa fa-slideshare fa-fw"></i>SlideShare</a>
    </li>
    

    

    
    <li class="pure-menu-item">
      <a class="pure-menu-link" href="https://linkedin.com/in/seandavi" target="_blank"><i class="fa fa-linkedin-square fa-fw"></i>LinkedIn</a>
    </li>
    

    

    

    

    

    

    
    <li class="pure-menu-item">
      <a class="pure-menu-link" href="https://github.com/seandavi" target="_blank"><i class="fa fa-github-square fa-fw"></i>GitHub</a>
    </li>
    

    

    
    <li class="pure-menu-item">
      <a class="pure-menu-link" href="https://bitbucket.org/seandavi" target="_blank"><i class="fa fa-bitbucket-square fa-fw"></i>Bitbucket</a>
    </li>
    

    

    

    

    

    

    

    

    

    

    

  </ul>
</div>


  <div>
  <div class="small-print">
    <small>&copy; 2017 Sean Davis</small>
  </div>
  <div class="small-print">
  </div>
</div>

</div>


  <div id="main">


    <div class="header">
      <h1 itemprop="name">Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer.</h1>
    </div>

<div class="content">
  <div class="container">
    
    <span class="pub-authors" itemprop="author">
      
      L Zhang, Y Zhang, A Mehta, M Boufraqech, S Davis, J Wang, Z Tian, Z Yu, MB Boxer, JA Kiefer, JA Copland, RC Smallridge, Z Li, M Shen, E Kebebew
      
    </span>
    <div>
      May 5, 2015
    </div>

    <div class="abstract">
      Anaplastic thyroid cancer (ATC) is one of the most lethal human malignancies that currently has no effective therapy. We performed quantitative high-throughput screening (qHTS) in three ATC cell lines using 3,282 clinically approved drugs and drug candidates, and identified 100 active agents. Enrichment analysis of active compounds showed that inhibitors of EGFR and histone deacetylase (HDAC) were most active. Of these, the first-in-class dual inhibitor of EGFR, HER2 and HDACs, CUDC-101, had the highest efficacy and lower IC50 than established drugs. We validated that CUDC-101 inhibited cellular proliferation and resulted in cell death by inducing cell cycle arrest and caspase-dependent apoptosis. CUDC-101 also inhibited cellular migration in vitro. Mechanistically, CUDC-101 inhibited MAPK signaling and histone deacetylation in ATC cell lines with multiple driver mutations present in human ATC. The anticancer effect of CUDC-101 was associated with increased expression of p21 and E-cadherin, and reduced expression of survivin, XIAP, Î²-catenin, N-cadherin, and Vimentin. In an in vivo mouse model of metastatic ATC, CUDC-101 inhibited tumor growth and metastases, and significantly prolonged survival. Response to CUDC-101 treatment in vivo was associated with increased histone 3 acetylation and reduced survivin expression. Our findings provide a preclinical basis to evaluate CUDC-101 therapy in ATC.
    </div>

    
<div id="disqus_thread"></div>
<script type="text/javascript">

(function() {
    
    
    if (window.location.hostname == "localhost")
        return;

    var dsq = document.createElement('script'); dsq.type = 'text/javascript'; dsq.async = true;
    var disqus_shortname = 'seandavi-github-io';
    dsq.src = '//' + disqus_shortname + '.disqus.com/embed.js';
    (document.getElementsByTagName('head')[0] || document.getElementsByTagName('body')[0]).appendChild(dsq);
})();
</script>
<noscript>Please enable JavaScript to view the <a href="http://disqus.com/?ref_noscript">comments powered by Disqus.</a></noscript>
<a href="http://disqus.com/" class="dsq-brlink">comments powered by <span class="logo-disqus">Disqus</span></a>

  </div>
</div>

</div>
</div>
<script src="/js/ui.js"></script>


<script>
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

  ga('create', 'UA-93043521-1', 'auto');
  ga('send', 'pageview');

</script>



</body>
</html>
